🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Provocative talks at #IGCS2022 - is there a neoadjuvant group who do NOT benefit from interval debulking for ovarian CA? Perhaps CA125 kinetics can identify patients with highly sensitive disease for whom chemo alone is equivalent . . .

KGOG enters the HIPEC discussion at #IGCS2022 for interval debulking with a new RCT finding an 8 mo improved PFS and substantial OS benefit (median OS not yet reached for HIPEC group but highly significant) for both Stage III and IV patients. More HIPEC to come?

Uterine transposition to mid abdomen for preservation of fertility in patients receiving non GYN cancer related pelvic radiation. A potential new frontier. #IGCS2022, #fertilitypreservation

PromMise-2 - simplifying endometrial CA molecular classification with a one-step DNA based test! More exciting science at #IGCS2022 IGCS

More interesting findings #igcs2022 SAVE trial for hypofractionated vaginal cuff brachytherapy (2 doses x 11 Gy) comparable to longer courses in early followup

How to treat Stage IB2 cervical cancer with fertility preservation? A debate at #igcs2022

🚨Results from GOG238🚨: cisRT vs RT for local recurrence at #IGCS2022 : no benefit to adding cis but confirms long term survival from RT salvage for local recurrences

Excellent presentation of benefit of topotecan, taxol and bevacizumab (TPB) on PFS compared to non-TPB in cervical neuroendocrine tumors IJGC IJGC Fellows ESGO IGCS SGO Michael Frumovitz MD Anderson Cancer Center #NeCTur

🚨LEOPARD study finds 0% node positivity rate for early stage Grade 1 endometrioid ovarian cancers, even among patients undergoing extensive lymphadnectomy #IGCS2022

Our next gyn onc biomarker? cfHPV DNA for monitoring therapeutic response in cervical ca. Exciting work from Suzana Mittelstadt at #igcs202 ⁦IGCS⁩

Great study by Dr. Melissa Pham at #igcs2022 on molecular markers for predicting everolimus response for recurrent endometrial cancer !

Excited to be back with ERAS Society USA for the #erasusa 2022 meeting! Great to see the latest advocates for enhanced recovery after surgery come together!

Great to be ERAS Society USA with our #MGB residency alums !

Excited for ERAS Society USA’s 7th annual meeting! Thanks to Baylor Scott & White Dallas-Fort Worth for co-hosting with us this year

Our keynote speaker Angie Balfour, chair of the ERAS® Society nursing group gets us pumped about ERAS. Delighted to have her from Scotland 🏴󠁧󠁢󠁳󠁣󠁴󠁿 here in Dallas for ERAS Society USA

👏 fantastic to see our Brigham and Women's Hospital nurses ERAS Society USA

We applaud President Donald J. Trump Biden's proclamation of April as National Cancer Prevention and Early Detection Month and the Administration's focus on the importance of prevention and early detection as vital components to achieving the goals of the #CancerMoonshot. bit.ly/43NilG3

Best team ever! Hui Shen from Van Andel Institute (VAI) , Chuck Drescher from @Fredhut, and Jarrod Marto from Dana-Farber. Surprising results on impact of BRCA mutations on the Fallopian tubes. BasserBRCA Penn Medicine CSO Penn Center for Genome Integrity nature.com/articles/s4146…